Table 1.

Clinicopathological Features and Other Variables of Breast Carcinoma

Characteristics		n (%)
Age	< 50 years	52 (40)
	≥ 50 years	78 (60)
Grade	moderate-poor	111 (85.4)
	well	19 (14.6)
Size	≥ 2 cm	107 (82.3)
	< 2cm	23 (17.7)
Lymph node	positive	78 (60)
	negative	52 (40)
Stage	IIIA	32 (24.6)
	I-II	98 (75.4)
Sub- types	Luminal	70 (53.8)
	Non-Luminal	60 (46.2)
VEGF-C	≥ 10%	109 (83.8)
	< 10%	21 (16.2)
VEGFR-3	≥ 10%	114 (87.7)
	< 10%	16 (12.3)
LVD	High	56 (43.1)
	Low	74 (56.9)
LVI	Yes	92 (70.8)
	No	38 (29.2)
Survival	Dead	38 (29.2)
	Alive	92 (70.8)
Therapy	Anthracycline based	60 (46.5)
	Taxane based	70 (53.5)